GAN-based quantitative oblique back-illumination microscopy enables computationally efficient epi-mode refractive index tomography.
Journal
Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
received:
01
05
2024
revised:
09
06
2024
accepted:
10
06
2024
medline:
30
9
2024
pubmed:
30
9
2024
entrez:
30
9
2024
Statut:
epublish
Résumé
Quantitative oblique back-illumination microscopy (qOBM) is a novel imaging technology that enables epi-mode 3D quantitative phase imaging and refractive index (RI) tomography of thick scattering samples. The technology uses four oblique back illumination images captured at the same focal plane and a fast 2D deconvolution reconstruction algorithm to reconstruct 2D phase cross-sections of thick samples. Alternatively, a through-focus z-stack of oblique back illumination images can be used to recover 3D RI tomograms with improved RI quantitative fidelity at the cost of a more computationally expensive reconstruction algorithm. Here, we report on a generative adversarial network (GAN) assisted approach to reconstruct 3D RI tomograms with qOBM that achieves high fidelity and greatly reduces processing time. The proposed approach achieves high-fidelity 3D RI tomography using differential phase contrast images from three adjacent z-planes. A ∼9-fold improvement in volumetric reconstruction time is achieved. We further show that this technique provides high SNR RI tomograms with high quantitative fidelity, reduces motion artifacts, and generalizes to different tissue types. This work can lead to real-time, high-fidelity RI tomographic imaging for
Identifiants
pubmed: 39346989
doi: 10.1364/BOE.528968
pii: 528968
pmc: PMC11427205
doi:
Banques de données
figshare
['10.6084/m9.figshare.26014279']
Types de publication
Journal Article
Langues
eng
Pagination
4764-4774Informations de copyright
© 2024 Optica Publishing Group.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.